MRMD — Marimed Income Statement
0.000.00%
- $64.54m
- $119.71m
- $148.60m
- 46
- 93
- 27
- 56
Annual income statement for Marimed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 45.6 | 50.9 | 121 | 134 | 149 |
Cost of Revenue | |||||
Gross Profit | 18.7 | 31.3 | 66.3 | 64 | 65.9 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 87.2 | 36.4 | 94.6 | 114 | 145 |
Operating Profit | -41.6 | 14.5 | 26.9 | 20.4 | 3.95 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -81.9 | 4.5 | 23.8 | 19.5 | -6.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -81.9 | 2.43 | 7.62 | 13.6 | -16 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -81.2 | 2.14 | 7.22 | 13.5 | -16 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -81.2 | 2.14 | 7.22 | 13.5 | -16 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.376 | 0.007 | 0.019 | 0.037 | -0.024 |